Influence of Multiplex PCR in the Management of Antibiotic Treatment in Patients with Bacteremia
- PMID: 37370357
- PMCID: PMC10295051
- DOI: 10.3390/antibiotics12061038
Influence of Multiplex PCR in the Management of Antibiotic Treatment in Patients with Bacteremia
Abstract
The multiplex PCR assay can be a helpful diagnostic tool for patients with bacteremia. Herein, we assessed the impact of a Blood Culture Identification Panel (BCID) on both the diagnosis and treatment of patients with bacteremia. We performed a retrospective study using laboratory and clinical data to evaluate the impact of syndromic testing using a multiplex PCR testing system (BioFire® FilmArray) for the management of patients with bloodstream infections. BCID detected the pathogen in 102 (87.9%) samples out of the 116 positive blood cultures tested. The average time from the blood culture collection to the communication of the molecular test result was 23.93 h (range: 10.67-69.27 h). The main pathogen detected was Klebsiella pneumoniae (17.6%). The antimicrobial therapy was changed in accordance with the BCID results in 28 (40.6%) out of the 69 cases, wherein the treatment could have been theoretically adjusted. This allowed the adjustment of the therapy to be performed 1305.1 h faster than it would have been possible if conventional diagnostic methods had been used; this was the case for only 35.1% of the time gained if treatment was adjusted for all patients with positive BCID. Thus, although molecular tests can make a difference in the management of bloodstream infections, there is room for improvement in the clinical application of BCID results.
Keywords: antimicrobial therapy; blood cultures; multiplex PCR testing system.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;23:801–810. doi: 10.1001/jama.2016.0287. - DOI - PMC - PubMed
-
- Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., Reinhart C.K., Suter P.M., Thijs L.G. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–710. doi: 10.1007/BF01709751. - DOI - PubMed
-
- Li A., Ling L., Qin H., Arabi Y.M., Myatra S.N., Egi M., Kim J.H., Mat Nor M.B., Son D.N., Fang W.F., et al. Epidemiology, Management, and Outcomes of Sepsis in ICUs among Countries of Differing National Wealth across Asia. Am. J. Respir. Crit. Care Med. 2022;9:1107–1116. doi: 10.1164/rccm.202112-2743OC. - DOI - PubMed
LinkOut - more resources
Full Text Sources